Navigation Links
A new significance of LVD and angiogenic MVD is identified in human primary SCRC
Date:1/16/2008

Lymphangiogenesis and angiogenesis are critical processes for tumor growth, invasion and metastasis. Angiogenesis has established its role in the development and progression of a variety of malignancies, playing a crucial role in the dissemination of the tumor cells. However, because of the lack of specificity lymphatic endothelial makers that could be used to discriminate between lymphatics and blood vessels, the definite significance of lymphangiogenesis in sporadic colorectal carcinoma (SCRC) was not very clear.

A research article to be published on January 7, 2008 in the World Journal of Gastroenterology (volume 14, issue 1) addresses this question. The research team led by Pr. Xiang Du from Cancer Hospital, Fudan University, has investigated the lymphatic vessel density (LVD) and microvessel density (MVD) in tumoral areas of 132 cases with primary SCRC. Of the 132 cases, 74 were metastatic cases and 58 non-metastatic cases, which were evaluated by immunohistochemistry, using antibodies of D2-40 and von Willebrand factor (vWF) respectively. In addition, the researchers detected them by double labeling immunohistochemistry to prove the specificity of D2-40.

One conclusion reported by the investigators is that the lymphatic vessels and microvessels at central portions of SCRC often had a reticular architecture, with numerous tiny and ill-defined lumina, while those at tumor borders had large and open lumina. The LVD and MVD were both obviously higher in the cases of colorectal carcinoma with metastasis than in cases without metastasis. For each one lymphatic vessel increased, there was a 1.45-fold increase in the risk of metastasis in SCRC, and for each one microvessel increased, there was a 1.11-fold increase. The specificity and sensitivity of LVD in predicting metastasis or non-metastasis in SCRC were both higher than LVD.

Another conclusion is that high LVD, high MVD, co-accounting of high LVD and high MVD were associated with patients' poor disease-free survival and co-accounting of LVD and MVD was an independent prognostic factor of colorectal carcinoma.

In addition, double labeling immunohistochemistry showed D2-40 immunoreactivity was specific for lymphatic vessels.


'/>"/>

Contact: Jing Zhu
wjg@wjgnet.com
0086-105-908-0039
World Journal of Gastroenterology
Source:Eurekalert

Related medicine news :

1. EpiCept to Present Preclinical Studies of EPC2407 in Combination With Anti-Angiogenic and Chemotherpeutic Agents at the AACR-NCI-EORTC International Conference
2. Study shows blood markers can help choose best dose for antiangiogenic drugs
3. Chemical culprit in popcorn workers lung identified
4. High and mighty: first common height gene identified by researchers behind obesity gene finding
5. The genes involved in rheumatoid arthritis identified
6. Justice Department to Hold Media Event to Demonstrate New Database for Matching Unidentified Remains and Missing Persons Information
7. Normal role for schizophrenia risk gene identified
8. Unique role for blood formation gene identified
9. Second pathway behind HIV-associated immune system dysfunction identified
10. Common Early-Warning Symptoms of Ovarian Cancer Identified in CDC/Thomson Healthcare Study
11. 3 New Lung Cancer Genes Identified
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... , ... February 10, 2016 , ... ... announces that his office is now offering a variety of comprehensive procedures for ... enhancement, eyebrow lift, facial volume restoration, lip enhancement and nasal reshaping. , ...
(Date:2/10/2016)... AZ (PRWEB) , ... February 10, 2016 , ... Ongoing ... the Aging Life Care Association™ (ALCA) to conduct a survey that takes a closer ... experts released today illustrates the prevalence and causes of TBI among the aging population, ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... welcomes S.S. Nesbitt as the latest addition to its growing list of Partner ... locations throughout the Southeast, from Orlando to Huntsville and in between. , Harnessing ...
(Date:2/10/2016)... ... February 10, 2016 , ... AxoGen, Inc. (NASDAQ: AXGN), a leading ... the fourth quarter and full year ended December 31, 2015 on Monday, February 29, ... webcast for the investment community following the release at 4:30 PM ET. Investors interested ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... ... four time Emmy award winner and inspirational speaker Jan Fox will serve as ... by Speaking Boldly will provide participants with tools to more effectively communicate with ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... YORK , Feb. 10, 2016 Immune ... biopharmaceutical company, announced today that it has filed a ... Leukemia and other cancers. --> ... treating cancer by administration of Ceplene (histamine dihydrochloride) in ... provides methods of predicting the efficacy of Ceplene and ...
(Date:2/10/2016)... , Feb. 10, 2016  The ALS Association, in partnership ... Grand Challenge to generate a biomarker to track TDP43 aggregation. ... up to a $1 million investment. ... disease that affects nerve cells in the brain and the ... initiate and control muscle movement, which often leads to total ...
(Date:2/10/2016)... 10, 2016 Convergence scenarios are ... various technologies that results in diverse solutions ... opportunities create a cyclical system where technology ... the development of new technologies. ... technology convergences, which are constantly fostering new ...
Breaking Medicine Technology: